| Jessica Ann Licari, OTR/L | |
|
433 Orange Dr, Altamonte Springs, FL 32701-5377 | |
| (407) 260-2433 | |
| Not Available |
| Full Name | Jessica Ann Licari |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 433 Orange Dr, Altamonte Springs, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215700810 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 23861 (Florida) | Primary |
| Provider Name | Empowerme Rehabilitation Florida, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1184257602 PECOS PAC ID: 3274962790 Enrollment ID: O20200406000039 |
News Archive
According to a major investment bank there would be no smokers in Britain by 2050. According to Citigroup analyst Adam Spielman the decline is sharp and sure and would show up as no smokers in 30 to 50 years time. The analyses used data to reveal that the percentage of adult smokers in the UK has fallen from 53 per cent in 1960 to 21 per cent in 2008. Spielman said, "If these trends continue, then by 2050 many important tobacco markets will have gone to zero smoking."
High-grade serous ovarian cancer often responds well to the chemotherapy drug carboplatin, but why it so frequently comes back after treatment has been a medical mystery.
Surgeons in the Heart Center at Boston Children's Hospital have partnered with Edwards Lifesciences to launch a clinical study of a new prosthetic heart valve for patients born with a congenital heart defect.
After a traumatic brain injury, the most harmful damage is caused by secondary swelling of the brain compressed inside the skull. There is no treatment for this.
Optimer Pharmaceuticals, Inc. today announced that it has submitted the first section of a rolling New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for fidaxomicin to treat patients with Clostridium difficile infection (CDI) and to prevent recurrences of CDI. Optimer anticipates completing the submission in the fourth quarter of 2010 and plans to request priority review, which, if granted, could lead to an FDA decision on the NDA in the second quarter of 2011.
› Verified 8 days ago
| Provider Name | Onr National Speech Pathology Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1972965952 PECOS PAC ID: 2668463522 Enrollment ID: O20210528001837 |
News Archive
According to a major investment bank there would be no smokers in Britain by 2050. According to Citigroup analyst Adam Spielman the decline is sharp and sure and would show up as no smokers in 30 to 50 years time. The analyses used data to reveal that the percentage of adult smokers in the UK has fallen from 53 per cent in 1960 to 21 per cent in 2008. Spielman said, "If these trends continue, then by 2050 many important tobacco markets will have gone to zero smoking."
High-grade serous ovarian cancer often responds well to the chemotherapy drug carboplatin, but why it so frequently comes back after treatment has been a medical mystery.
Surgeons in the Heart Center at Boston Children's Hospital have partnered with Edwards Lifesciences to launch a clinical study of a new prosthetic heart valve for patients born with a congenital heart defect.
After a traumatic brain injury, the most harmful damage is caused by secondary swelling of the brain compressed inside the skull. There is no treatment for this.
Optimer Pharmaceuticals, Inc. today announced that it has submitted the first section of a rolling New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for fidaxomicin to treat patients with Clostridium difficile infection (CDI) and to prevent recurrences of CDI. Optimer anticipates completing the submission in the fourth quarter of 2010 and plans to request priority review, which, if granted, could lead to an FDA decision on the NDA in the second quarter of 2011.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Ann Licari, OTR/L 2549 Maitland Crossing Way Apt 11-305, Orlando, FL 32810-7111 Ph: (678) 967-9406 | Jessica Ann Licari, OTR/L 433 Orange Dr, Altamonte Springs, FL 32701-5377 Ph: (407) 260-2433 |
News Archive
According to a major investment bank there would be no smokers in Britain by 2050. According to Citigroup analyst Adam Spielman the decline is sharp and sure and would show up as no smokers in 30 to 50 years time. The analyses used data to reveal that the percentage of adult smokers in the UK has fallen from 53 per cent in 1960 to 21 per cent in 2008. Spielman said, "If these trends continue, then by 2050 many important tobacco markets will have gone to zero smoking."
High-grade serous ovarian cancer often responds well to the chemotherapy drug carboplatin, but why it so frequently comes back after treatment has been a medical mystery.
Surgeons in the Heart Center at Boston Children's Hospital have partnered with Edwards Lifesciences to launch a clinical study of a new prosthetic heart valve for patients born with a congenital heart defect.
After a traumatic brain injury, the most harmful damage is caused by secondary swelling of the brain compressed inside the skull. There is no treatment for this.
Optimer Pharmaceuticals, Inc. today announced that it has submitted the first section of a rolling New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for fidaxomicin to treat patients with Clostridium difficile infection (CDI) and to prevent recurrences of CDI. Optimer anticipates completing the submission in the fourth quarter of 2010 and plans to request priority review, which, if granted, could lead to an FDA decision on the NDA in the second quarter of 2011.
› Verified 8 days ago
Dr. Jeffrey Kenneth Miller, DPT, MOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 652 Palm Springs Dr, Altamonte Springs, FL 32701 Phone: 407-389-1092 Fax: 407-389-1097 | |
Ms. Lourdes Paez, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 498 Palm Springs Dr Ste 345, Altamonte Springs, FL 32701 Phone: 407-494-0644 Fax: 407-494-0644 | |
Barbara Martinez, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 633 Greencove Ter Apt 148, Altamonte Springs, FL 32714 Phone: 407-682-2768 | |
Sylvia Gallo, OTL, CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 Douglas Ave, Ste 103, Altamonte Springs, FL 32714 Phone: 407-865-7153 Fax: 407-865-7159 | |
Angela Knowlton, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 711 E Altamonte Dr Ste 200, Altamonte Springs, FL 32701 Phone: 407-305-5465 | |
Mrs. Lindsay Montague Renninger, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1249 S Timberland Trl, Altamonte Springs, FL 32714 Phone: 407-342-9767 |